Opioid-sparing effect of erector spinae plane block and intravenous dexmedetomidine for obese patients with obstructive sleep apnea: A randomized controlled trial

Opioid-sparing Effect of Erector Spinae Plane Block and Intravenous Dexmedetomidine for Obese Patients with Obstructive Sleep Apnea: A Randomized Controlled Trial

Objective:

This study aimed to evaluate the impact of erector spinae plane block (ESPB) and intravenous (IV) dexmedetomidine in reducing opioid consumption after bariatric surgery and their effects on post-operative recovery, pain relief, and lung functions.

Design:

A randomized controlled trial.

Location:

Tanta University Hospitals, Tanta, Gharboa, Egypt.

Participants:

Forty obese patients with obstructive sleep apnea syndrome (OSAS), aged 20-55 years, eligible for bariatric surgery.

Interventions:

Patients were assigned to group I (received general anesthesia with opioid, sham ESPB, and IV normal saline) or group II (received general anesthesia without opioid, ESPB at T7 level using 20 mL bupivacaine 0.25%, and bolus IV dexmedetomidine 1 µg/kg followed by 0.25 µg/kg/h).

Main Outcome Measures:

Recorded outcomes included perioperative fentanyl consumption (primary outcome), sevoflurane consumption, recovery time, Visual Analog Scale (VAS) scores, and pulmonary functions.

Results:

Group II showed significantly lower perioperative fentanyl and sevoflurane consumption compared to group I (p = 0.010, <0.001, <0.001, and <0.001, respectively). Group II also had shorter recovery time (p < 0.001) and lower VAS scores at various post-operative time points. Postoperative pulmonary function did not significantly change, but oxygen desaturation was significantly lower in group II (p = 0.001).

Conclusions:

ESPB with IV dexmedetomidine benefits OSAS patients undergoing bariatric surgery by reducing opioid use, shortening recovery time, providing adequate pain relief, and minimizing complications. However, it did not significantly affect post-operative pulmonary function.

PMID:

39017616

DOI:

10.5055/jom.0873

Clinical trials play a crucial role in developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research, making it easily accessible for clinicians.

In today’s healthcare environment, streamlining operations is essential. Our mobile apps support scheduling, treatment monitoring, and telemedicine, simplifying patient care management and digital service expansion.

By leveraging AI, clinics can enhance workflows, improve patient outcomes, and reduce paper-based routines. Discover how we can assist at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.